The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.
 
Gottfried E. Konecny
Consulting or Advisory Role - Novartis
Research Funding - Amgen; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Aminah Jatoi
Research Funding - Boston Biologics; Entera Health
 
Jill K. Burton
No Relationships to Disclose
 
Jill Paroly
No Relationships to Disclose
 
John A. Glaspy
No Relationships to Disclose
 
Sean Christopher Dowdy
No Relationships to Disclose
 
Dennis J. Slamon
No Relationships to Disclose